| 07.08 12:55 | dpa-AFX: *CVS HEALTH NOW EXPECTS FY24 GAAP EPS OF $4.95 TO $5.20, ADJ. EPS OF $6.40 TO $6.65 |
| 07.08 12:54 | dpa-AFX: *CVS HEALTH Q2 ADJ. EPS $1.83 VS. $2.21 LAST YEAR |
| 07.08 12:54 | dpa-AFX: *CVS HEALTH Q2 TOTAL REVENUES $91.234 BLN VS. $88.921 BLN LAST YEAR |
| 07.08 12:53 | dpa-AFX: *CVS HEALTH Q2 OPERATING INCOME $3.045 BLN VS. $3.234 BLN LAST YEAR |
| 07.08 12:53 | dpa-AFX: *CVS HEALTH Q2 NET INCOME $1.770 BLN VS $1.901 BLN LAST YEAR |
| 07.08 12:49 | dpa-AFX: ROUNDUP: CVS Health Cuts FY24 Earnings View Below Market; Stock Down In Pre-market |
| 07.08 12:34 | dpa-AFX: CVS Health Corp. Q2 Profit Decreases, But Beats Estimates |
| 07.08 12:32 | dpa-AFX: *CVS HEALTH Q2 GAAP EPS $1.41 VS. $1.48 LAST YEAR |
| 07.08 12:02 | dpa-AFX: CVS Health Q2 24 Earnings Conference Call At 8:00 AM ET |
| 06.08 19:33 | X verklagt Werbevereinigung wegen geschäftsschädigendem Boykott |
| 08.07 15:19 | dpa-AFX: *CVS HEALTH CORP. (CVS) DECLARES QUARTERLY DIVIDEND OF $ 0.665, RECORD DATE 7/22/2024 |
| 08.07 15:18 | dpa-AFX: *CVS HEALTH DECLARES QUARTERLY DIVIDEND OF $0.665/SHR, PAYABLE AUG. 01, RECORD JULY 22 |
| 16.05 13:03 | dpa-AFX: *CVS PHARMACY ANNOUNCES THE LAUNCH OF WELL MARKET |
| 01.05 22:08 | MÄRKTE USA/Leichter - Dow & Co mit Strohfeuer nach Fed-Kommentaren |
| 01.05 18:20 | MÄRKTE USA/Sorgen vor falkenhafter Fed bremsen weiter |
| 01.05 15:37 | dpa-AFX: *CVS HEALTH MIT -18% AN S&P-100-ENDE - GEWINNAUSBLICK GESTUTZT |
| 01.05 15:08 | dpa-AFX: Pre-market Movers: IMCC, CVRX, TGTX, ROOT, PLTN. |
| 01.05 13:03 | dpa-AFX: CVS Health Q1 24 Earnings Conference Call At 8:00 AM ET |
| 01.05 12:49 | dpa-AFX: ROUNDUP: CVS Health Slashes FY24 Outlook; Stock Down 11% |
| 01.05 12:41 | dpa-AFX: *CVS HEALTH VORBÖRSLICH -11% - GEWINNAUSBLICK GESTUTZT |
|
|
